Article History
Accepted: 14 May 2021
First Online: 26 May 2021
Declarations
:
: The in vivo lung deposition study was performed as per the procedures and guidelines of the Committee for the Purpose of Control and Supervision of Experimental Animals (CPCSEA), India, at the Institute of Chemical Technology, Mumbai, India. The experiments were performed on receiving approval of the animal study protocol submitted to the Institutional Animal Ethics Committee (IAEC) of the Institute of Chemical Technology (Protocol no. IAEC/ICT/2017/P56: To study the biodistribution of developed novel nanoformulation for tuberculosis via pulmonary route).
: The authors declare no competing interests.